期刊文献+

老年人骨质疏松性骨折治疗药物研究进展 被引量:3

下载PDF
导出
摘要 骨质疏松症是一种以低骨量和骨组织微结构破坏为特征,导致骨骼脆性增加和易发生骨折的全身性疾病。本病是老年人的一种常见病,随着人们寿命的延长,社会的老龄化,其发生率逐渐上升。骨折等并发症可致残、致死、耗资大,给患者、家庭和社会带来沉重的负担。因此,骨质疏松症的防治已成为一个世界性的重要公共卫生问题之一。
作者 朱艳玲
出处 《中国疗养医学》 2009年第8期722-723,共2页 Chinese Journal of Convalescent Medicine
  • 相关文献

参考文献2

  • 1蔡久波,白云,肖明.骨质疏松性骨折治疗药物研究进展[J].实用医药杂志,2006,23(2):228-230. 被引量:2
  • 2J.-Y. Reginster,H. W. Minne,O. H. Sorensen,M. Hooper,C. Roux,M. L. Brandi,B. Lund,D. Ethgen,S. Pack,I. Roumagnac,R. Eastell. Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis[J] 2000,Osteoporosis International(1):83~91

二级参考文献15

  • 1Adinoff AD,Hollister JR.Steroid-induced fractures and bone loss in patients with asthma.N Engl J Med,1983,309:265.
  • 2American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis,Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis:2001 update.Arthritis Rheum,2001,44:1496.
  • 3Black DM,Arden NK,Palermol,et al.Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures.Study of Osteoporotic Fractures Research Group.J Bone Miner Res,1999,14:821.
  • 4Cooper C,Atkinson EJ.Incidence of clinically diagnosed vertebral fractures:a population-based study in Rochester,Minnesota,1985-1989.J Bone Miner Res,1992,7:221.
  • 5Rossouw J,Anderson G,Prentice R,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative Randomized Controlled Trial.JAMA,2002,288:321.
  • 6Neer RM,Arnaud CD,Zanchetta JR,et al.Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis.N Engl J Med,2001,344:1434.
  • 7Levis S,Quandt SA,Thompson D,et al.Alendronate reduces the risk of multiple symptomatic fracture:results from the Fracture Intervention Trial.J Am Geriatr Soc,2002,50:409.
  • 8Alendronate Once-Weekly Study Group.Two-year results of onceweekly administration of alendronate 70mg for the treatment of postmenopausal osteoporosis.J Bone Miner Res,2002,17:1988.
  • 9Reginster J,Minne HW,Sorensen OH,et al.Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis.Vertebral Efficacy With Risedronate Therapy(VERT)Study Group.Osteoporos Int,2000,11:83.
  • 10Watts NB,Adami S,Chesnut C.Risedronate reduces the risk of clinical vertebral fractures in just 6 months.J Bone Miner Res,2001,16(suppl 1):s407.

共引文献1

同被引文献25

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部